CINIT 23 - 2nd Congress international of novation & innovation therapeutics.

Dear Guests and Attendees of the 2nd International Congress Of Novation & Innovation Therapeutics,

We are honored to welcome you to this historic event, where we are gathering the brightest minds and experts in the clinical research field. We are here to discuss, exchange, and work together to find innovative solutions to the most complex challenges facing our society today. We are confident that this meeting will be inspiring for all participants, and we look forward to seeing the fruits of our collective work.

Welcome to all!

Pr Houda Filali

President of the Moroccan Society of Pharmacology and Therapeutics

Specialist in clinical pharmacology and geriatrics

Professor of Higher Education in Pharmacology

MBA in Marketing & Management of health and health products

Head of pharmacovigilance CHU Ibn Rochd

Assistant director of the cancer research laboratory cedoc ss uh2

Head of the cancer pharmacology and therapeutics research team.

Head of international R&D projects for health products

Head of FMPC experimental research platform

The requirements for clinical research are constantly increasing, making it a real issue of national sovereignty involving strategic activities for patients and health professionals, industrials, research organizations and the State.
Clinical trials in generally, and particularly the ones carried out on drugs for human use, including biological products, are an essential element in the process of developing new drugs and biosimilars. They present a medicoeconomic opportunity for access to diagnostic and therapeutic progress, thereby contributing to the reputation and dyna- mism of the country's medical sector.
It is therefore crucial and strategic for Morocco to develop an ecosystem conducive to the conduct of clinical trials, a fin order to increase the interest of the national industry to develop its pipeline, to meet the Royal and governmental will of national sovereignty, and become a regional leader and an attractive center of competitiveness.
Because of this, it seems important that we ask ourselves about the necessary motivations to boost local clinical research, to make our regulatory and ethical system more credible and fluid, taking into account the specificities of our population and our professional skills. This will allow our country to position itself as a regional hub and as a partner of choice internationally.
We are all convinced of our strengths to succeed in this challenge!!!
Today, the use of personalized data is growing at all levels including clinical research. Real life studies and therapeutic value determination in clinical research. Real-life studies and strategic therapeutic value determination of biological molecules, we have a great opportunity to develop biosimilars. All of these opportunities require a conducive clinical research ecosystem, high motivation and tangible involvement of the government apparatus. This requires the promotion of a clinical research culture among policy makers and health professionals, coupled with an awareness of scientific progress and a sense of volunteerism among the general public.
In fine, clinical trials open up defining horizons for ensuring optimal health for all, a fin consolidating interprofessional collaboration and communication, and fostering considerable economic growth and technological development for a self-suffising, innovative, attractive and competitive Morocco

Office members of SMPT

Pr F. Hali

Vice President
Pr S. Sahraoui

Vice President
Dr Y. Kadil

Treasurer Read More
Pr M. Zamd

SECRETARIAT
Mme M. Ouhakki

SECRETARIAT
Pr A. Meftah

Assistant Treasurer
Pr A. Ouladlahsen

SECRETARIAT

C3M

Dr S. Kaddar

Founding President of C3M

Healthcare institutions are facing complex and multiple challenges: an increasingly ageing population, a rise in chronic diseases, the emergence of new issues (health promotion, ageing disability, social isolation, etc.), an increase in social and territorial inequalities in health, lack of access to medical care, the rising cost of certain treatments, expectations of personalized approaches to care, etc., as well as obvious financial constraints on the healthcare ecosystem and certain general constraints such as climate change, energy shortages and the growing scarcity of resources.
Our findings point to the emergence of a broad spectrum of innovative responses to these challenges: technological innovations, products, and services, organizational and managerial innovations, innovations in business models, renewal of R&D processes, innovations in governance, management, and evaluation, public regulation, often inspired by New Public Governance (NPG) (Torfing, Triantafillou, 2013), and, finally, innovations that renew the range of actors in these movements...
Morocco is not left out in this context. Today, it proclaims loud and clear its desire to make its own decisions without interference and to be the sole master of its destiny. However, it will have to make up for its lack of investment in the knowledge base compared to other countries.
In this regard, improving the conditions and access to funding for research and innovation, to ensure that innovative ideas, both from university laboratories and from research and development (R&D) departments, can be efficiently transformed into products and services that create growth and employment. This could have a positive impact on the creation of jobs and consequently on the national GDP.
This second International Congress of Innovation Therapeutics is an opportunity to promote, at the national and regional level, a collective intelligence that opens the way to invest in research and innovation.

Honorary presidents of the SMPT

Pr M. Slaoui

Professor of Immunology at the University of Mons, Belgium
Chief Scientific Advisor to Operation Warp Speed
Member of the board of directors of GSK PLC;
Chairman of Pharmaceutical R&D;
Chairman Global R&D, Vaccines & Oncology; and Chairman, Global Vaccines.
Partner at Medicxi

The ability to judge a nation's scientific position is vital for governments, corporations and trusts who must decide on science priorities and funding. The basics of knowledge and economic fortune of a nation are maintained and developed through the production of highly qualified talent, this is what I expressed last year by “need to invest in the talent ! ". This is a necessary but not sufficient condition for economic development. sustainable. Other factors such as political and macroeconomic, including investments in infrastructure must also be in place to maintain this development . Moreover, private sector investment in public sector research enables and encourages interaction and the transfer of knowledge between business and higher education and therefore is critical to the development of a nation's talent and knowledge.
While the essential health needs of populations around the world “The Global Health” take precedence over the interests of particular nations, the reality today is that the very vast majority of research and talent is located in developed countries. To rebalance this imbalance, research must be relaunched as a priority, in developing countries to enable them to develop the tools necessary to improve their state of health, which is now apprehended by international organizations.
The question of R&D for the health of low- and moderate-income countries is the subject of discussions at the global governance bodies such as the WHO. Unfortunately, his registration in the international political agenda will be slow and it will not be smooth, due to the differences points of view between the many and diverse protagonists and the balance of power in their negotiations. A debate on the model or models to undertake for low-cost R&D would be in order.
Last year, I was asked the question "where should we start to promote research in Morocco ? and my answer was “maybe by the end!! ". Clinical trials still hold a place more central in the biomedical field because today, their role is no longer limited to the development and to the regulation of therapeutic practices and strategies. Indeed, carrying out a clinical trial has become simultaneously a tool for implementing therapies as well as a privileged means of investigation and development of fundamental knowledge on pathogenic, genomic and more broadly on human biology. To encourage such trials, a legal and ethical framework should develops to adapt to these transformations and to the evolution from the world of diagnostic and therapeutic research.

Pr M. Aboumaarouf

Pr A. Benider

Pr F. Chehab

Pr C. Nejjari

Expert From World

Passionate Event Speakers

We are very pleased to welcome eminent specialists, known for their expertise in their respective fields, to share their knowledge and experience with us at this congress.

Don’t Miss This Event

The International Congress Of The Year

Research and therapeutic innovation Evaluation and Trends.

Day 01 full Program

9 June, 2023

08h00-08H30/Reception - Congress Registration

08h30-09H00

Welcoming note

Pr H. Filali

President of the Moroccan Society of Pharmacology and Therapeutics

09h00-09H20

Continuous Professional Development for health professionals in Morocco

Moderation : Pr S. Sahraoui, Pr F. Hali

Pr H. Louardi

09h20-09H40

Strategy and scientific potential in Morocco

Moderation : Pr S. Sahraoui, Pr F. Hali

Pr H. Bouabid

09h40-10H00

Why clinical trials in Morocco ?

Moderation : Pr S. Sahraoui, Pr F. Hali

Dr M. Hakim

Coffee break & visit of the stands

10h30-12h30

MasterClass 1 : Regulation & Submission of clinical study files to the competent authorities

Moderation

Speakers

Presentation of legal texts governing biomedical research
Preparation of documents for : CEPP, CNDP, DMP
Specificity of certain studies and additional documents

Moderation : Pr F. Hakkou,Pr N. Zerouali

Pr J E Ktiouet, Pr N. Tahiri,Dr M. Hakim, Dr G. Lyamani,

10h30-12h30

MasterClass 2 : Pharmaceutical performance and biotechnology

Moderation

Speakers

improvement of finished products
The role of formulation science in the various stages of drug development
Trends and deﬁs in formulation development
Moroccan regulatory requirements
Relationship Structure Activity and improvement of the Benefit/Risk contribution of the health product

Moderation : Pr Y. Bousliman, Dr I. Haouach

Dr M. Haiytam Ayad, Pr Y. Khayati, Pr A. Benmoussa

10h30-12h30

MasterClass 3 : Conducting a clinical research project in accordance with regulations

Moderation

Speakers

Classify the different Clinical Research according to the levels of regulations
Prepare the authorizations requested according to the pro le the research conducted
Write a clinical research protocol
Control PCBs & management of EIs
Know the methods of managing experimental drugs
Present practical cases of setting up and monitoring clinical research Clinical Research

Moderation : Pr C. Nejjari

Pr S. Nani, Pr S. Hassoune, Dr R. Lamrini, Dr M. Alami, Dr A. Elmaouhoub

Lunch Break

14h00-16h00

MasterClass 4 : Real-life studies for the evaluation of health products: the evidence tested in current practice (Onco-Hemato practical cases, rare pathologies)

Moderation

Speakers

The interest of real-life studies (RWD)
Methodology, quality, relevance and evaluations
The legal and ethical framework
RWD/RWE
Strategic issues for the health system
Case study Onco-Hematology, Rare pathologies

Moderation : Pr S. Sahraoui, Pr J. Ktiouet

Présenté par : Dr S. Boutayeb, Dr G. Lyamani, Dr H. Sahri , CNDP/DLEM

14h00-16h00

MasterClass 5 : Impact of Precision Medicine and Individualized Therapeutics (Case Studies Nephorology - Rheumatology, Rare Diseases)

Coordinators

Speakers

Evolution of sequencing technologies and AI involvement in favor of MP
State of play, perspectives and priority themes of MP in the Morocco: feedback
Pharmacogenetics and role in improving approaches therapies: practical examples
Economic, legal, ethical and societal dimensions of MP
Involvement of AI in MP and individualized therapy: review of experience
Obstacles and challenges for the industry

Coordination : Pr A. Maaroufi, Pr M. Slaoui, Dr S. Bouchene

Pr E. Elfahim, Pr H. Dihazi

14h00-16h00

MasterClass 6 : Biosimilars: Opportunities and Challenges

Coordinators

Moderation

Speakers

Design and development methodology
Ecosystem and Biotechnology Infrastructure
Regulatory issues EMA/FDA/Morocco
Medico-economic impact
Intellectual Property Management

Coordination : Pr R. Lamrini,

Moderation : Pr S. Machour

Dr A. Elouhhabi, Dr I. Haouach /LCM

Coffee break & visit of the stands

16h30-17h15

Opening session

Pr. A. Miraoui

Excellency the Minister of Higher Education, Scientific Research and Innovation.

Mr N. Bourita

Excellency the Ministry of Foreign Affairs, African Cooperation and Moroccan Expatriates

Pr. K. Aït Taleb

Excellency the Minister of Health and Social Protection

Pr. H. Filali

President of the SMPT

Moderation : Pr S. Sahraoui, Pr F. Hali

17h15-19h00

Plenary Session

Pr M. SLAOUI

Clinical Trials: Strengthening and Accelerating the Attractiveness Process

Dr H.M Ayad

Open Innovation in life sciences

Dr H. Ramzy

Feedback: Socio-health and economic impact of clinical trials

Dr E. Baseilhac

Access to innovation: What strategies to accelerate the emergence of diagnostic & therapeutic innovation for the benefitﬁce of patients?

Dr S. Machour

Achieving national and African health sovereignty.

Discussion

Day 02 full Program

10 June, 2023

09h00-10H00

Moroccan Research and Innovation : National Initiatives and Partnership

Ministry of Higher Education: National Center for Biotechnology Research
CNRST: How to promote health research?
PCNT: Role of health clusters/ Partnerships
Erasmus Morocco: Role of international partnerships and benefits of mobility
C3M: The role of Moroccan medical and scientific expertise in the development of international partnerships and the promotion of research
IP: Feedback and industrial motivation

Pr A. Ezzarfi, Pr A. Maaroufi, Pr A. Ziadi , Pr N. Elouad, Dr K. Zaher
Moderation : Pr Y. Elfakir, Pr N. Zerouali

10h00-11H00

Opening up universities to the business world - a real lever for clinical research

University Presidents: Visions and Implementation.
FMP: Role and strategies
University Hospital Directors: How to develop partnerships
PI: Identiﬁcation of needs and areas for partnership
C3M: “Student entrepreneur” projects

Pr A. Benana, Pr B. Lekehal, A. Chahboune, Dr E. Baseilhac, Pr G. Malka, Pr A. Zahouani
Moderation : Pr M. Aboumaarouf

Coffee break & visit of the stands

11h30-12h30

Which Ecosystem for the promotion and acceleration of clinical research in Morocco?

Ministry of Health and Social Protection

PI: Motivation of nationals and involvement of regions

CGEM: Funding CGEM/Ministry of Industry/Research Center serving medical R&D

INSERM: Feedback

Pr A. Mrabti, Pr A. Ibrahimi, Mr K. Amor, Pr J E Ktiouet, Pr A. Benazzouz, Dr A. Sekhri
Moderation : Pr M. Slaoui, Pr C. Nejjari

12h30-13h30

Health Regionalization Policy: Impact on Clinical Research and Access to Innovation

Performance Improvements / Creation of centers of excellence
Decentralization
Intersectoral coordination
Equity of access to care

Pr R.Bekkali, Pr Y. Barakkat, Dr A. Alaoui, Dr I. Mouhlal, Dr M. El Bouhmadi
Moderation : Dr S. Kaddar,Dr A. Belghiti

Lunch Break

Moderation : Pr S. Ahid, Dr E. Baseilhac, Dr A. Alaoui, Dr M. Benazouz.

16h30 - 16h50

Contribution of therapeutic innovation in the management of schizophrenia and Pharmaco-economic implications

Dr I. Kendili

16h50-17H10

Apport de la Modélisation des Analyses d'Impact Budgétaire dans les Traitements Innovants : Cas de la Darbepoetin Alpha en Dialyse.

Pr A. Maoujoud

Discussion

17h20-17H40

Innovation for remaining unmet needs in diabetes

Pr F. El guendouz

Discussion

18h10 - 18h30

Digital transformation at the heart of innovation and access to the best care services

Pr A. Doukkali

Summary, recommendations and closing

Pr M. Slaoui, Pr H. Filali

dinner cocktail & Networking

Moderation : Pr M. Errasfa, Pr. M Zamd, Pr Y. Bousliman, Dr A. Matraoui

14h30-14h50

Cannabis: From the plant to the laboratory

The place of synthetic cannabinoid acids in the management of serious diseases.

Dr F. M Delacourt

14h50-15h10

Foodstuffs Intended for Special Medical Purposes: Regulation and Issues

Dr A. Zahouani

15h20-15h40

Plant biotechnology in pharmaceutical and cosmetic development

Dr A. Zhiri

15h40-16h00

Biosimilars, opportunities and challenges.

Dr A. Elouhhabi

Coffee break & visit of the stands

Pr K. Marhoum El Filali, Dr M S. Afif, Dr M. Seqat

15h20-15h40

Morocco: Between the hope of therapeutic innovations and the dilemma of access (Case of Pediatric Endocrinology)

Pr F. Jennane

Disscussion

Moderation : Pr F. Hali, Pr A. Ouladlahssen, Dr A. Barry, Dr H. Dihazi

14h30-14h50

Promotion of telemedicine (TLM) in Morocco

Pr Y. Elfakir

14h50-15h10

AI in precision therapy

Pr S. Boutayeb

15h20-15h40

Development of creativity and innovation in health

Pr H. Chelly

15h40-16h00

Connected medicine through wearable devices and AI diagnostic assistance

Mr K. Amor

Coffee break & visit of the stands

Moderation : Pr. M. El Fahim, Pr T Abousaouira,Pr N J Tahiri

14h30-14h50

Stem/progenitor cell therapy for the treatment of liver disease

Dr M. Najimi

14h50-15h10

Restoration of lung and intestinal functions by cell and gene therapy using human stem cells

Dr S. Assou

Discussion

Moderation : Pr J E Ktiouet, Pr Y Khebbal, Pr D. Tanani

14h30-14h50

Therapeutic innovation for neurological and psychiatric disorders

Pr A. Benazzouz

14h50-15h10

Geriatric medical cannabis and neurodegenerative disease, what's new in 2023

Pr R. Rabii

15h20-15h40

The House of the Brain: an innovative approach to cross-functional management patient centered

Dr R. Bouali-Benazzouz

Coffee break & visit of the stands

Moderation : Dr M S. Aﬁf, Dr Ouldghiri

16h30-17h00

Contribution of therapeutic innovation in the management of schizophrenia and pharmaco-economic implications

Dr I. Kandily

17h00-17h30

Advances in Onco-Hematology

17h30-18h00

Advances in Diabetology

18h00-18h30

Pediatric endocrinology in Morocco: Between the hope of therapeutic innovations and the dilemma of access

Pr F. Jennane

18h30-18h45

Digital transformation at the heart of innovation and access to the best care services

Pr A. Doukkali

18h45-19h00

Synthesis, recommendations and closure

Pr M. Slaoui, Pr H. Filali

Dinner & Networking

Moderation: Pr Y. Barakkat, Dr E. Baseilhac, Dr A. Alaoui, Dr N. Malhouf

15h40-16h00

Innovative DM to improve the quality of life of the elderly

Dr. J M Mauclaire

Coffee break & visit of the stands

Day 03 full Program

11 June, 2023

10h00-11H00

Signature of Partnerships

11h00-13H00

Cultural visit of the city of Tangier
Visit UHC Mohamed VI Tangier
Late Checkout

Registration & Accommodation

Hilton Tangier Al Houara Resort & Spa

^DHs3500

Registration

Pack 1

Access to congress
Access to One Free Master Class & sessions
(+1000DH for extra Master Class)
Coffee break
Dinner with soft drinks

^DHs7500

Registration + 2 nights / Single room

Pack 2

Single room in B2B
Access to congress
Access to One Free Master Class & sessions
(+1000DH for extra Master Class)
Coffee break
Dinner with soft drinks

^DHs8100

Registration + 2 nights / Double rooms

Pack 3

Double rooms in B2B
Access to congress
Access to One Free Master Class & sessions
(+1000DH for extra Master Class)
Coffee break
Dinner with soft drinks

^DHs1500

Registration

Pack 1

Access to congress
Coffee break
Dinner with soft drinks

^DHs5500

Registration + 2 nights / Single room

Pack 2

Single room in B2B
Access to congress
Coffee break
Dinner with soft drinks

^DHs6100

Registration + 2 nights / Double rooms

Pack 3

Double rooms in B2B
Access to congress
Coffee break
Dinner with soft drinks

Hilton Garden Inn Tanger City Center

^DHs3500

Registration

Pack 1

Access to congress
Access to One Free Master Class & sessions
(+1000DH for extra Master Class)
Coffee break
Dinner with soft drinks

^DHs6500

Registration + 2 nights / Single room

Pack 2

Single room in B2B
Access to congress
Access to One Free Master Class & sessions
(+1000DH for extra Master Class)
Coffee break
Dinner with soft drinks

^DHs7100

Registration + 2 nights / Double rooms

Pack 3

Double rooms in B2B
Access to congress
Access to One Free Master Class & sessions
(+1000DH for extra Master Class)
Coffee break
Dinner with soft drinks

^DHs1500

Registration

Pack 1

Access to congress
Coffee break
Dinner with soft drinks

^DHs4500

Registration + 2 nights / Single room

Pack 2

Single room in B2B
Access to congress
Coffee break
Dinner with soft drinks

^DHs5100

Registration + 2 nights / Double rooms

Pack 3

Double rooms in B2B
Access to congress
Coffee break
Dinner with soft drinks

Our Great Sponsors

We are excited to work with the partners below to deploy and improve the solutions we imagine every day.

Collaborators

Top Attractions in Tangier

SOUK OF TANGIER

Tanger

The Grand Souk is the commercial center of the city, it is one of the most frequented by residents of the city and by tourists.

CAVES OF HERCULES

Tanger

The Caves of Hercules are magnificent limestone caves with which several Greek myths are associated

CAP SPARTEL

Tanger

This picturesque promontory is an ideal place to escape the crowds of the old town and you will find a lighthouse there which dates from the 19th century. It is located near the Caves of Hercules, so consider visiting both sites together, either by tourist bus or by hiring a private taxi.

DAR EL MAKHZEN

Tanger

It is the former palace of the khalifa, Dar el Makhzen was founded in 1684 by Sultan Moulay Ismail just after the departure of English troops from Tangier, the latter served as a residence for the representative of the Sultan under the protectorate, as a courthouse and cash.

MEDINA ART GALLERY

Tanger

The Mohamed-Drissi contemporary art gallery, formerly called the Museum of Contemporary Art and renamed in honor of the Moroccan artist in 2006, is a museum whose building served as the British consulate for much of the 20th century. .

MUNICIPAL BEACH

Tanger

The sea is calm and warm, with vast expanses of sand to make the most of the sun. Children's clubs and nautical activity clubs such as jet-skiing are available on the beach.

Dear Guests and Attendees of the 2nd International Congress Of Novation & Innovation Therapeutics,

Pr Houda Filali

President of the Moroccan Society of Pharmacology and Therapeutics

Specialist in clinical pharmacology and geriatrics

Professor of Higher Education in Pharmacology

MBA in Marketing & Management of health and health products

Head of pharmacovigilance CHU Ibn Rochd

Assistant director of the cancer research laboratory cedoc ss uh2

Head of the cancer pharmacology and therapeutics research team.

Head of international R&D projects for health products

Head of FMPC experimental research platform

Office members of SMPT

Dr Youness Kadil

Pr F. Hali

Pr S. Sahraoui

Dr Y. Kadil

Pr M. Zamd

Mme M. Ouhakki

Pr A. Meftah

Pr A. Ouladlahsen

C3M

Dr S. Kaddar

Founding President of C3M

Honorary presidents of the SMPT

Pr M. Slaoui

Professor of Immunology at the University of Mons, Belgium Chief Scientific Advisor to Operation Warp Speed Member of the board of directors of GSK PLC; Chairman of Pharmaceutical R&D; Chairman Global R&D, Vaccines & Oncology; and Chairman, Global Vaccines. Partner at Medicxi

Expert From World

Passionate Event Speakers

Don’t Miss This Event

The International Congress Of The Year

Day 01 full Program

9 June, 2023

08h00-08H30/Reception - Congress Registration

Welcoming note

Pr H. Filali

Continuous Professional Development for health professionals in Morocco

Pr H. Louardi

Strategy and scientific potential in Morocco

Pr H. Bouabid

Why clinical trials in Morocco ?

Dr M. Hakim

Coffee break & visit of the stands

MasterClass 1 : Regulation & Submission of clinical study files to the competent authorities

Pr J E Ktiouet, Pr N. Tahiri,Dr M. Hakim, Dr G. Lyamani,

MasterClass 2 : Pharmaceutical performance and biotechnology

Dr M. Haiytam Ayad, Pr Y. Khayati, Pr A. Benmoussa

MasterClass 3 : Conducting a clinical research project in accordance with regulations

Pr S. Nani, Pr S. Hassoune, Dr R. Lamrini, Dr M. Alami, Dr A. Elmaouhoub

Lunch Break

MasterClass 4 : Real-life studies for the evaluation of health products: the evidence tested in current practice (Onco-Hemato practical cases, rare pathologies)

Présenté par : Dr S. Boutayeb, Dr G. Lyamani, Dr H. Sahri , CNDP/DLEM

MasterClass 5 : Impact of Precision Medicine and Individualized Therapeutics (Case Studies Nephorology - Rheumatology, Rare Diseases)

Pr E. Elfahim, Pr H. Dihazi

MasterClass 6 : Biosimilars: Opportunities and Challenges

Dr A. Elouhhabi, Dr I. Haouach /LCM

Coffee break & visit of the stands

Opening session

Pr. A. Miraoui

Mr N. Bourita

Pr. K. Aït Taleb

Pr. H. Filali

Moderation : Pr S. Sahraoui, Pr F. Hali

Plenary Session

Pr M. SLAOUI

Dr H.M Ayad

Dr H. Ramzy

Dr E. Baseilhac

Dr S. Machour

Discussion

Day 02 full Program

10 June, 2023

Moroccan Research and Innovation : National Initiatives and Partnership

Pr A. Ezzarfi, Pr A. Maaroufi, Pr A. Ziadi , Pr N. Elouad, Dr K. Zaher Moderation : Pr Y. Elfakir, Pr N. Zerouali

Opening up universities to the business world - a real lever for clinical research

Pr A. Benana, Pr B. Lekehal, A. Chahboune, Dr E. Baseilhac, Pr G. Malka, Pr A. Zahouani Moderation : Pr M. Aboumaarouf

Coffee break & visit of the stands

Which Ecosystem for the promotion and acceleration of clinical research in Morocco?

Pr A. Mrabti, Pr A. Ibrahimi, Mr K. Amor, Pr J E Ktiouet, Pr A. Benazzouz, Dr A. Sekhri Moderation : Pr M. Slaoui, Pr C. Nejjari

Health Regionalization Policy: Impact on Clinical Research and Access to Innovation

Pr R.Bekkali, Pr Y. Barakkat, Dr A. Alaoui, Dr I. Mouhlal, Dr M. El Bouhmadi Moderation : Dr S. Kaddar,Dr A. Belghiti

Professor of Immunology at the University of Mons, Belgium
Chief Scientific Advisor to Operation Warp Speed
Member of the board of directors of GSK PLC;
Chairman of Pharmaceutical R&D;
Chairman Global R&D, Vaccines & Oncology; and Chairman, Global Vaccines.
Partner at Medicxi

Pr A. Ezzarfi, Pr A. Maaroufi, Pr A. Ziadi , Pr N. Elouad, Dr K. Zaher
Moderation : Pr Y. Elfakir, Pr N. Zerouali

Pr A. Benana, Pr B. Lekehal, A. Chahboune, Dr E. Baseilhac, Pr G. Malka, Pr A. Zahouani
Moderation : Pr M. Aboumaarouf

Pr A. Mrabti, Pr A. Ibrahimi, Mr K. Amor, Pr J E Ktiouet, Pr A. Benazzouz, Dr A. Sekhri
Moderation : Pr M. Slaoui, Pr C. Nejjari

Pr R.Bekkali, Pr Y. Barakkat, Dr A. Alaoui, Dr I. Mouhlal, Dr M. El Bouhmadi
Moderation : Dr S. Kaddar,Dr A. Belghiti